Sai Life Sciences Ltd (NSE:SAILIFE) Share Price

Company Profile

Business description
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possesses both; discovery/contract research (CRO) and chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment: contract research, development, and manufacturing. Geographically it operates in India as well as Outside India.
Contact
Gachibowli Miyapur Road
L4- 01 & 02, SLN Terminus Survey, Survey no. 133
Gachibowli
HyderabadTG500032
IND
T: +91 4068156000
https://www.sailife.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 March 2026
Employees
3,401

Recommended

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

William Kerwin, CFA | 12 January 2026

The shares are overvalued as investors are overly excited about defence and gold exposure.

Esther Holloway | 12 January 2026

Our view on the potential for additional offers.

Esther Holloway | 11 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,138.50	11.40	0.12%
CAC 40	8,350.38	8.38	-0.10%
DAX 40	25,504.93	99.59	0.39%
Dow JONES (US)	49,590.20	86.13	0.17%
FTSE 100	10,129.10	11.60	-0.11%
HKSE	26,848.47	239.99	0.90%
NASDAQ	23,733.90	62.56	0.26%
Nikkei 225	53,549.16	1,609.27	3.10%
NZX 50 Index	13,656.05	27.24	-0.20%
S&P 500	6,977.27	0.00	0.00%
S&P/ASX 200	8,808.50	17.20	0.20%
SSE Composite Index	4,138.76	26.53	-0.64%